1133 related articles for article (PubMed ID: 17925454)
1. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
2. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction.
Raney MA; Yee AJ; Todd MK; Turcotte LP
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E592-8. PubMed ID: 15547141
[TBL] [Abstract][Full Text] [Related]
3. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
4. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle and heart LKB1 deficiency causes decreased voluntary running and reduced muscle mitochondrial marker enzyme expression in mice.
Thomson DM; Porter BB; Tall JH; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E196-202. PubMed ID: 16926377
[TBL] [Abstract][Full Text] [Related]
6. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation.
Dzamko N; Schertzer JD; Ryall JG; Steel R; Macaulay SL; Wee S; Chen ZP; Michell BJ; Oakhill JS; Watt MJ; Jørgensen SB; Lynch GS; Kemp BE; Steinberg GR
J Physiol; 2008 Dec; 586(23):5819-31. PubMed ID: 18845612
[TBL] [Abstract][Full Text] [Related]
7. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
8. AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity.
Janovská A; Hatzinikolas G; Staikopoulos V; McInerney J; Mano M; Wittert GA
Mol Cell Endocrinol; 2008 Mar; 284(1-2):1-10. PubMed ID: 18255222
[TBL] [Abstract][Full Text] [Related]
9. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.
Lee WJ; Kim M; Park HS; Kim HS; Jeon MJ; Oh KS; Koh EH; Won JC; Kim MS; Oh GT; Yoon M; Lee KU; Park JY
Biochem Biophys Res Commun; 2006 Feb; 340(1):291-5. PubMed ID: 16364253
[TBL] [Abstract][Full Text] [Related]
10. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
Sakamoto K; Göransson O; Hardie DG; Alessi DR
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
[TBL] [Abstract][Full Text] [Related]
11. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment.
Steinberg GR; Rush JW; Dyck DJ
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E648-54. PubMed ID: 12441311
[TBL] [Abstract][Full Text] [Related]
12. Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction.
Jensen TE; Rose AJ; Jørgensen SB; Brandt N; Schjerling P; Wojtaszewski JF; Richter EA
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1308-17. PubMed ID: 17213473
[TBL] [Abstract][Full Text] [Related]
13. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
[TBL] [Abstract][Full Text] [Related]
14. Influence of malonyl-CoA and palmitate concentration on rate of palmitate oxidation in rat muscle.
Merrill GF; Kurth EJ; Rasmussen BB; Winder WW
J Appl Physiol (1985); 1998 Nov; 85(5):1909-14. PubMed ID: 9804598
[TBL] [Abstract][Full Text] [Related]
15. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
Tomas E; Tsao TS; Saha AK; Murrey HE; Zhang Cc Cc; Itani SI; Lodish HF; Ruderman NB
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16309-13. PubMed ID: 12456889
[TBL] [Abstract][Full Text] [Related]
16. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line.
Habinowski SA; Hirshman M; Sakamoto K; Kemp BE; Gould SJ; Goodyear LJ; Witters LA
Arch Biochem Biophys; 2001 Dec; 396(1):71-9. PubMed ID: 11716464
[TBL] [Abstract][Full Text] [Related]
17. AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo.
Shearer J; Fueger PT; Rottman JN; Bracy DP; Martin PH; Wasserman DH
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E871-7. PubMed ID: 15265760
[TBL] [Abstract][Full Text] [Related]
18. Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activated.
Winder WW; Holmes BF
J Appl Physiol (1985); 2000 Dec; 89(6):2430-7. PubMed ID: 11090599
[TBL] [Abstract][Full Text] [Related]
19. Role of the atypical protein kinase Czeta in regulation of 5'-AMP-activated protein kinase in cardiac and skeletal muscle.
Ussher JR; Jaswal JS; Wagg CS; Armstrong HE; Lopaschuk DG; Keung W; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E349-57. PubMed ID: 19625676
[TBL] [Abstract][Full Text] [Related]
20. Low-intensity contraction activates the alpha1-isoform of 5'-AMP-activated protein kinase in rat skeletal muscle.
Toyoda T; Tanaka S; Ebihara K; Masuzaki H; Hosoda K; Sato K; Fushiki T; Nakao K; Hayashi T
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E583-90. PubMed ID: 16249251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
